Articles of Covid-19

News »

Cecmed approves clinical trials with Abdala in pediatric age group

niña vacuna covid

The study will include 592 children and adolescents between three and 18 years of age. The Center for State Control of Medicines, Equipment and Medical Devices (Cecmed), on July 2, approved the initiation of clinical trials in the pediatric age group of Cuba’s anti-COVID candidate vaccine Abdala, produced by the Center for Genetic Engineering and Biotechnology. As reported on the Mesa Redonda television program, the trials will include 592 children and adolescents between three and 18 years of age.

News »

Isle of Youth vaccinated, hope grows on the big island

Isla Juventud

The completion of the sanitary intervention here ,with Cuba’s Abdala candidate vaccine, qualifies as a milestone in the country’s battle against COVID-19, with the regimen of three doses administered to the Isle of Youth’s 50,503 inhabitants, 95.6% of the eligible population. Dr. Victor Doeste Hernandez, coordinator of the intervention, reported to Granma that this figure represents 77% of residents over 19 years of age and 60% of the total population on the Isle of Youth.

News »

Cinicial trials of Soberana-Pediatria in children 3-11 years of age begin

niños vacuna covid

The study of the Cuban anti-COVID candidate vaccine will include 350 children and adolescents, 50 in Phase I and 300 in Phase II, conducted in an overlapping and gradual process, in strict compliance with protocols and best practices. Following verification of the candidate’s safety in a group of adolescents aged 12 to 18, clinical trials of Soberana-Pediatria continue with the inclusion of a second group of volunteers in the three to 11 age group, Yury Valdes Balbin, assistant director of the Finlay Vaccine Institute, reported.

News »

Abdala, with three doses, demonstrates 92.28% efficacy

Canel Abdala

Communist Party First Secretary and President of the Republic Miguel Díaz-Canel Bermúdez, on behalf of Cuba, congratulates researchers who in 13 months achieved a global milestone. A three-dose regimen of the Abdala candidate vaccine has demonstrated an efficacy of 92.28 percent, placing it well above the World Health Organization (WHO) requirement of at least 50 percent, to be recognized as an anti-COVID-19 vaccine.

News »

Soberana is a go!

Canel cientificos

There is a small island country, bathed in the waters of the Caribbean. A country as small as David, with the same courage when the time comes to face a giant. A small country that has struggled and struggles. A small country dressed in olive green. A country with sons and daughters who wage their battle looking into a microscope, wearing a white lab coat.

News »

Over 9,000 patients have received regenerative medicine treatment in Villa Clara

medicos Villa Clara

The Regenerative Medicine Services Center in the central province of Villa Clara has treated over 9,300 individuals since its creation ten years ago. Mainly serving those living in the region, they have significantly improved quality of life with the use of innovative techniques. “The use of regenerative medicine seeks to repair, replace and regenerate cells, tissues and organs with the aim of restoring or recovering the regular functioning of the body,” explains Dr. Manuel Antonio Arce González, researcher at the Unit of Biomedical Research in Villa Clara and head of the Regenerative Medicine Services in the territory.

News »

Clinical trial of candidate vaccine in pediatric age group begins, with strict protocols observed

Cuba Vacuna

With the vaccination of the first 25 volunteers in the 12-18 age group, Phase I clinical trials in pediatric ages of the Soberana 02 candidate anti-COVID vaccine developed by the Finlay Vaccine Institute (IFV) began yesterday, June 14. As anticipated, the process was initiated at the Juan Manuel Márquez Pediatric Hospital in Havana, strictly adhering to protocols, with all the rigor and organization required, beginning the first day.

News »

Cuba begins Covid-19 vaccine clinical trial in pediatric ages

Cuba-Vacunacion-Infantil

Cuba has begun on Monday phases I/II of the clinical trials of its Soberana 02 and Soberana Plus Covid-19 vaccines on Children and teenagers, with two doses of the former and one of the later. Approved on June 10 by the Center for State Control of Medicines, Equipment and Medical Devices (CECMED), this trials that will take place at the Juan Manuel Marquez Pediatric Hospital in Havana will be sequential, open and adaptive for three to 18 years of age.

News »

Family avoids mental fatigue associated with Covid-19 in Cuba

tpfamiliacovidCuba

Professor Olga Esther Infante, from the University of Medical Sciences of Havana, explained that the term ‘pandemic exhaustion’ is perceived by the Cuban family, a concept coined by the World Health Organization in reference to a state of fatigue, lack of motivation and apathy. Infante specified in a televised conference that this lack of motivation leads to a relaxation of personal self-care and increases the risk of contagion, as well as affectations among group members such as irritability and manifestations of anxiety that can generate conflicts.

News »

Diaz-Canel highlights childhood protection programs in Cuba

Cuba-ninos

Cuban President Miguel Diaz-Canel on Saturday highlighted his country’s child protection programs against any kind of exploitation, a principle established in the national legal system. On his Twitter account, the president said that the prohibition of child labor is one of the elements of the right to employment in Cuba and added that the State guarantees the protection of minors and their interests, according to international law and commitments.